Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
A director at Fold Holdings, Inc. recently purchased a notable amount of the company’s common stock. This insider buying activity is reported against a backdrop of mixed corporate performance, including underwhelming first-quarter financial results and significant market fluctuations. Concurrently, the firm secured a $150 million credit facility to…
William Brian Poppic Reeves, CEO and a ten percent owner of Fold Holdings, Inc., recently sold company stock valued at $18,519. The transactions were identified as 'sell to cover' sales mandated by tax withholding obligations related to restricted stock units. These moves occurred against a backdrop of significant stock pressure, where the stock ha…
Paul B. Prager, CEO and director of TeraWulf Inc., executed multiple stock sales totaling approximately $8.39 million over two days in late May 2026. These transactions occurred as the company's stock traded near its 52-week high following a significant year-long return. The article details the specifics of these sales and provides context regardin…
ContextLogic Holdings Inc. (NASDAQ:LOGC) director and ten percent owner Raja Bobbili recently increased his holdings by purchasing 130,201 shares of the company's common stock. These transactions, which totaled approximately $1,134,824, occurred over several days in late May 2026. The purchases were made while the stock was trading near its 52-week…
James E. Freeland, VP and Chief Information Officer at Digi International Inc., sold a small number of company shares in May 2026. This transaction occurred as Digi International's stock approached its 52-week peak following significant annual gains. Separately, the company reported robust financial results for the second quarter of fiscal 2026, ex…
John Fesko, President and Chief Business Officer of Natera, Inc., recently sold a block of common stock shares. This transaction occurred as the company reported mixed financial results for Q1 2026, highlighted by exceeding revenue expectations but missing earnings per share targets. Despite this variance, Natera also announced significant operatio…
Entities affiliated with Steven T. Mnuchin, a director of Satellogic Inc., reported the sale of 10 million Class A Common Stock shares for $97.7 million on May 26, 2026. This transaction occurs as the company has seen significant stock appreciation and reports strong operational metrics, including an Overweight rating from Cantor Fitzgerald and a m…
Solomon Moshkevich, President of Clinical Diagnostics at Natera, Inc., sold a block of common stock valued at $335,091 on May 26, 2026. The transaction was related to satisfying tax obligations following the vesting of restricted stock units (RSUs). Despite this sale and recent market volatility, Natera reported strong first-quarter revenue growth …
Rocket Lab Corp's Chief Financial Officer, Adam C. Spice, sold a total of $8.94 million worth of common stock on May 26, 2026. These sales were executed through pre-arranged 'sell-to-cover' transactions under a Rule 10b5-1 plan. Separately, the company announced significant progress in its missile defense sector, including passing a crucial System …
Entities within the JW Asset Management group, including JW Partners, LP and JW Opportunities Fund, LLC, executed a series of common share sales totaling approximately $6.64 million in late May from Establishment Labs Holdings Inc. (NASDAQ:ESTA). These transactions marked the reporting persons' departure as beneficial owners of more than 10% of the…
Howard Bernard Culang, Non-Executive Chairman of the Board at Radian Group Inc., recently sold a block of common stock. This transaction occurs against a backdrop of positive corporate developments for Radian, including robust first quarter financial results that surpassed expectations, an Outperform rating from RBC Capital, and significant leaders…
Michael N. Intrator, the CEO and President of CoreWeave, Inc. (CRWV), executed a sale of company shares valued at approximately $32.8 million on May 26, 2026. This disposition was conducted through a Rule 10b5-1 trading plan. Concurrently, CoreWeave announced major strategic moves, including the launch of unified agentic AI capabilities and securin…
Jack D. Cogen, a Director at CoreWeave, Inc., reported the sale of approximately 986,540 shares of Class A Common Stock on May 26, 2026. The total value of these insider sales was calculated at roughly $106.3 million. This activity occurs while CoreWeave stock has demonstrated substantial gains, achieving a 46% return over the past six months and a…
CoreWeave director Karen Boone sold a total of approximately $1.25 million worth of the company's Class A Common Stock on May 26, 2026. This transaction occurred while CoreWeave shares were trading at $106.87, following a recent 46% surge over six months. The sale involved both directly held shares and indirect sales through The Boone Family Trust.…
Rocket Lab Corp Chief Operations Officer Frank Klein sold common stock valued at approximately $6.3 million on May 26, 2026. These sales involved transactions structured as 'sell-to-cover' sales under a Rule 10b5-1 election. The report details the specific transaction amounts and weighted-average prices. Furthermore, recent corporate developments h…
Rocket Lab USA, Inc.'s executive management recently executed share sales totaling over $2.2 million. This insider activity occurred while the company announced significant operational achievements, including passing a critical System Requirements Review for a defense contract and finalizing the acquisition of Motiv Space Systems. These development…
Arjun Kampani, Senior Vice President and General Counsel at Rocket Lab Corp, executed multiple stock sales totaling over $14 million in late May 2026. These transactions occurred as RKLB traded near its 52-week high, a period marked by significant company achievements, including the completion of a major system requirements review for a defense con…
A director of Rein Therapeutics, Inc. (NASDAQ:RNTX), executed multiple open market purchases of common stock in late May 2026, totaling a reported investment value of $49,560. These transactions occurred during a period when the company's shares saw notable gains. Beyond the insider activity, recent corporate developments include the completion of …
Texas Roadhouse's Chief Business & Admin Officer, Christopher C. Colson, recently completed a sale of corporate stock. This transaction occurs against a backdrop of positive operational news for the company, including robust first-quarter fiscal 2026 sales growth and subsequent upward revisions to price targets from several major financial institut…
Jorge Celaya, Executive Vice President and Chief Financial Officer of Liquidity Services Inc. (NASDAQ: LQDT), executed a series of stock trades between May 26 and May 28, 2026. These transactions included selling shares totaling approximately $812,152, alongside acquiring additional common stock valued at roughly $432,500 through the exercise of op…
Andrew Bialecki, Co-Chief Executive Officer and Director of Klaviyo, Inc., executed a significant stock sale totaling approximately $3.1 million in May 2026. The transaction involved selling shares under a Rule 10b5-1 plan, occurring against a backdrop of recent financial performance and ongoing market valuation adjustments for the marketing automa…
Ambarella's Chief Executive Officer, Wang Feng-Ming, executed multiple sales of company stock totaling approximately $2.96 million in May 2026. This activity occurred as the stock traded close to its 52-week high and following a report of better-than-expected Q1 Fiscal Year 2027 earnings for the firm.
The Chief Financial Officer of Ambarella Inc., John Alexander Young, recently sold 400 shares of the company's common stock valued at $38,400. This divestiture occurred after Mr. Young acquired an equal number of shares by exercising non-qualified stock options. These transactions take place against a backdrop of strong Q1 Fiscal Year 2027 earnings…
Polaryx Therapeutics, Inc. (PLYX) recently saw an insider stock purchase from Mstone Partners Healthcare Ltd. This transaction occurred on May 27, 2026, when Mstone acquired 88,453 shares of common stock at $4.07 per share, totaling $360,003. The acquisition represents a private placement generating gross proceeds of $360,000 for the company.This i…
The recent sale of shares by a high-ranking executive at Lyft, Inc. (NASDAQ:LYFT) was reported as the company's Chief Legal Officer utilized a pre-scheduled trading plan. This transaction occurs amid significant market attention surrounding Lyft's valuation and strategic direction. The stock has seen a considerable decline over the past six months,…
